Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 169K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Ciurea, A. Articles by Zinkernagel, R. M. Search for Related Content PubMed PubMed Citation Articles by Ciurea, A. Articles by Zinkernagel, R. M. Social Bookmarking                            What's this?

Original Article

^a Institute for Experimental Immunology, University Hospital, CH-8091 Zürich, Switzerland
Department of Internal Medicine, University Hospital, B-West-5, Raemistrasse 100, CH-8091 Zürich, Switzerland.41-1-255-456741-1-255-1111

adrian.ciurea{at}dim.usz.ch

We have shown previously that neutralizing antibodies (nAbs) are important contributors to the long-term immune control of lymphocytic choriomeningitis virus infection, particularly if cytotoxic T cell responses are low or absent. Nevertheless, virus escape from the nAb response due to mutations within the surface glycoprotein gene may subsequently allow the virus to persist. Here we show that most of the antibody-escape viral mutants retain their immunogenicity. We present evidence that the failure of the infected host to mount effective humoral responses against emerging neutralization-escape mutants correlates with the rapid loss of CD4⁺ T cell responsiveness during the establishment of viral persistence. Similar mechanisms may contribute to the persistence of some human pathogens such as hepatitis B and C viruses, and human immunodeficiency virus.

Key Words: persistent infection • lymphocytic choriomeningitis virus • T helper cells • humoral responses • viral evasion

P. Klenerman's present address is Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Abbreviations used in this paper: GP, glycoprotein; LCMV, lymphocytic choriomeningitis virus; nAb, neutralizing Ab; tg, transgenic; VSV, vesicular stomatitis virus; VSV-IND, VSV Indiana; wt, wild-type.

© 2001 The Rockefeller University Press

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Li, H., Chien, P. C. Jr., Tuen, M., Visciano, M. L., Cohen, S., Blais, S., Xu, C.-F., Zhang, H.-T., Hioe, C. E. (2008). Identification of an N-Linked Glycosylation in the C4 Region of HIV-1 Envelope gp120 That Is Critical for Recognition of Neighboring CD4 T Cell Epitopes. J. Immunol. 180: 4011-4021 [Abstract] [Full Text]  
• Eschli, B., Zellweger, R. M., Wepf, A., Lang, K. S., Quirin, K., Weber, J., Zinkernagel, R. M., Hengartner, H. (2007). Early Antibodies Specific for the Neutralizing Epitope on the Receptor Binding Subunit of the Lymphocytic Choriomeningitis Virus Glycoprotein Fail To Neutralize the Virus. J. Virol. 81: 11650-11657 [Abstract] [Full Text]  
• Zimmermann, V. S., Casati, A., Schiering, C., Caserta, S., Hess Michelini, R., Basso, V., Mondino, A. (2007). Tumors Hamper the Immunogenic Competence of CD4+ T Cell-Directed Dendritic Cell Vaccination. J. Immunol. 179: 2899-2909 [Abstract] [Full Text]  
• Charalambous, A., Oks, M., Nchinda, G., Yamazaki, S., Steinman, R. M. (2006). Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin. J. Immunol. 177: 8410-8421 [Abstract] [Full Text]  
• Bertoletti, A., Gehring, A. J. (2006). The immune response during hepatitis B virus infection. J. Gen. Virol. 87: 1439-1449 [Abstract] [Full Text]  
• Brooks, D. G., Teyton, L., Oldstone, M. B. A., McGavern, D. B. (2005). Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection. J. Virol. 79: 10514-10527 [Abstract] [Full Text]  
• Orozco, J. J., Carter, J. J., Koutsky, L. A., Galloway, D. A. (2005). Humoral Immune Response Recognizes a Complex Set of Epitopes on Human Papillomavirus Type 6 L1 Capsomers. J. Virol. 79: 9503-9514 [Abstract] [Full Text]  
• Mwangi, W., Brown, W. C., Splitter, G. A., Zhuang, Y., Kegerreis, K., Palmer, G. H. (2005). Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection. J. Leukoc. Biol. 78: 401-411 [Abstract] [Full Text]  
• Benigni, F., Zimmermann, V. S., Hugues, S., Caserta, S., Basso, V., Rivino, L., Ingulli, E., Malherbe, L., Glaichenhaus, N., Mondino, A. (2005). Phenotype and Homing of CD4 Tumor-Specific T Cells Is Modulated by Tumor Bulk. J. Immunol. 175: 739-748 [Abstract] [Full Text]  
• Chang, J. J., Wightman, F., Bartholomeusz, A., Ayres, A., Kent, S. J., Sasadeusz, J., Lewin, S. R. (2005). Reduced Hepatitis B Virus (HBV)-Specific CD4+ T-Cell Responses in Human Immunodeficiency Virus Type 1-HBV-Coinfected Individuals Receiving HBV-Active Antiretroviral Therapy. J. Virol. 79: 3038-3051 [Abstract] [Full Text]  
• Chien, P. C. Jr., Cohen, S., Tuen, M., Arthos, J., Chen, P.-d., Patel, S., Hioe, C. E. (2004). Human Immunodeficiency Virus Type 1 Evades T-Helper Responses by Exploiting Antibodies That Suppress Antigen Processing. J. Virol. 78: 7645-7652 [Abstract] [Full Text]  
• Shoukry, N. H., Sidney, J., Sette, A., Walker, C. M. (2004). Conserved Hierarchy of Helper T Cell Responses in a Chimpanzee during Primary and Secondary Hepatitis C Virus Infections. J. Immunol. 172: 483-492 [Abstract] [Full Text]  
• Day, C. L., Walker, B. D. (2003). Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections. JEM 198: 1773-1777 [Full Text]  
• Hunziker, L., Ciurea, A., Recher, M., Hengartner, H., Zinkernagel, R. M. (2003). Public versus personal serotypes of a viral quasispecies. Proc. Natl. Acad. Sci. USA 100: 6015-6020 [Abstract] [Full Text]  
• Lopez-Bueno, A., Mateu, M. G., Almendral, J. M. (2003). High Mutant Frequency in Populations of a DNA Virus Allows Evasion from Antibody Therapy in an Immunodeficient Host. J. Virol. 77: 2701-2708 [Abstract] [Full Text]  
• Day, C. L., Lauer, G. M., Robbins, G. K., McGovern, B., Wurcel, A. G., Gandhi, R. T., Chung, R. T., Walker, B. D. (2002). Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection. J. Virol. 76: 12584-12595 [Abstract] [Full Text]  
• Hunziker, L., Recher, M., Ciurea, A., Martinic, M. M.A., Odermatt, B., Hengartner, H., Zinkernagel, R. M. (2002). Antagonistic Variant Virus Prevents Wild-type Virus-induced Lethal Immunopathology. JEM 196: 1039-1046 [Abstract] [Full Text]  
• Venturini, S., Mosier, D. E., Burton, D. R., Poignard, P. (2002). Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Gag- and Gag Peptide-Specific CD4+ T-Cell Clones from an HIV-1-Seronegative Donor following In Vitro Immunization. J. Virol. 76: 6987-6999 [Abstract] [Full Text]  
• Schuurhuis, D. H., Ioan-Facsinay, A., Nagelkerken, B., van Schip, J. J., Sedlik, C., Melief, C. J. M., Verbeek, J. S., Ossendorp, F. (2002). Antigen-Antibody Immune Complexes Empower Dendritic Cells to Efficiently Prime Specific CD8+ CTL Responses In Vivo. J. Immunol. 168: 2240-2246 [Abstract] [Full Text]  
• Ou, R., Zhou, S., Huang, L., Moskophidis, D. (2001). Critical Role for Alpha/Beta and Gamma Interferons in Persistence of Lymphocytic Choriomeningitis Virus by Clonal Exhaustion of Cytotoxic T Cells. J. Virol. 75: 8407-8423 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS